Track the Neuland Laboratories Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Neuland Laboratories Limited has published 20 public disclosures. Market capitalisation: €297.7bn. The latest transaction was reported on 26 March 2026 (Pledge). Among the most active insiders: Davuluri Saharsh Rao. Every trade is accessible without an account.
20
Insider Decl.
n/a
Thresholds
€33,317
9 ops.
Buy Volume
€29,295
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Neuland Laboratories Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹24,334.75.
16Σ signal
Buys €33,317€29,295 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,330 of 28,733 companies
52.0
score / 100
Value
27
Quality
78
FCF yld-0.2%
Earn yld1.2%
EV/EBITDA50.2x
ROE·
Gross mgn51%
Net mgn19%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Neuland Laboratories Limited is a company focused on the manufacturing of pharmaceutical products and chemicals. It primarily operates in the Indian market and is listed on the Bombay Stock Exchange.